Halozyme Therapeutics, Inc. (RV7.F) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close110.45

Open110.50

Day range110.30111.30

52-week range52.50111.30

Off day high0.00%

Off 52-week high0.00%

Volume13.00

Avg. volume (3M)95.00

Market cap12.63B

EPS (TTM)2.93

Forward P/E42.48

P/E ratio (TTM)37.99

Dividend yield—

Beta (5Y)0.88

Shares outstanding113.50M

Short interest—

Earnings dateAug 6, 2026

Analyst target—

Profit margin24.86%

Against its peers

Compare in full ›

	RV7.F	BMRN	LGND	REGN	URGN	ROIV
Market cap	12.63B	10.81B	6.16B	83.00B	1.75B	26.18B
P/E (TTM)	38.0	150.9	32.5	19.9	—	—
Forward P/E	42.5	8.7	25.8	13.0	13.8	-21.1
Price/book	99.1	1.7	6.4	2.6	-13.2	6.2
Dividend yield	—	—	—	0.47%	—	—
1-year change	+90.37%	+5.75%	+65.11%	+38.09%	+98.24%	+94.43%
Today	+0.77%	−1.10%	+0.78%	−0.17%	+2.01%	+3.81%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Halozyme Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
BioMarin Pharmaceutical Inc.BMRN · Biotechnology	10.81B	55.82	−1.10%
Ligand Pharmaceuticals IncorporatedLGND · Biotechnology	6.16B	308.78	+0.78%
Regeneron Pharmaceuticals, Inc.REGN · Biotechnology	83.00B	806.14	−0.17%
UroGen Pharma Ltd.URGN · Biotechnology	1.75B	35.72	+2.01%
Roivant Sciences Ltd.ROIV · Biotechnology	26.18B	36.25	+3.81%
RemeGen Co., Ltd.9995.HK · Biotechnology	39.85B	66.900	+3.72%
Ultragenyx Pharmaceutical Inc.RARE · Biotechnology	1.57B	15.95	−0.47%
Telix Pharmaceuticals LimitedTLX · Biotechnology	3.42B	10.07	−9.77%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Summit Therapeutics Inc.SMMT · Miami, FL Odds	12.78B	16.02	−0.44%
BridgeBio Pharma, Inc.BBIO · Palo Alto, CA	13.40B	68.55	+1.48%
Everest Medicines Limited1952.HK · Shanghai, China	12.75B	36.060	+6.69%
Corcept Therapeutics IncorporatedCORT · Redwood City, CA	12.67B	117.17	+0.62%
Jazz Pharmaceuticals plcJAZZ · Dublin, Ireland	13.86B	213.50	−0.12%
AnGes, Inc.4563.T · Ibaraki, Japan	11.97B	30.00	+3.45%
Ascentage Pharma Group International6855.HK · Suzhou, China	11.68B	31.260	+2.29%
Bio-Techne CorporationTECH · Minneapolis, MN	11.39B	72.60	+0.03%

Healthcare companies of a similar market value (12.54B).

Company	Mkt cap	Price	Today
Summit Therapeutics Inc.SMMT · Biotechnology Odds	12.78B	16.02	−0.44%
Encompass Health CorporationEHC · Medical Care Facilities	11.88B	120.43	−1.02%
Penumbra, Inc.PEN · Medical Devices	12.76B	324.03	−0.10%
Ramsay Health Care LimitedRHC.AX · Medical Care Facilities	12.52B	54.25	+0.28%
Ipsen S.A.IPN.PA · Drug Manufacturers - Specialty & Generic	12.54B	152.20	+0.20%
Ping An Healthcare and Technology Company Limited1833.HK · Health Information Services	12.32B	5.795	−0.86%
BridgeBio Pharma, Inc.BBIO · Biotechnology	13.40B	68.55	+1.48%
ICON Public Limited CompanyICLR · Diagnostics & Research	14.33B	185.73	+6.62%

Also based in San Diego, California, then elsewhere in California.

Company	Mkt cap	Price	Today
QUALCOMM IncorporatedQCOM · San Diego, CA Odds	190.17B	178.09	+1.35%
Illumina, Inc.ILMN · San Diego, CA	43.09B	285.36	+6.51%
Realty Income CorporationO · San Diego, CA	52.60B	55.59	−1.34%
SempraSRE · San Diego, CA	54.64B	83.56	+0.91%
ResMed Inc.RMD · San Diego, CA	34.76B	247.15	+0.67%
DexCom, Inc.DXCM · San Diego, CA	30.76B	81.51	−4.93%
LPL Financial Holdings Inc.LPLA · San Diego, CA Odds	25.38B	322.38	+0.16%
Neurocrine Biosciences, Inc.NBIX · San Diego, CA	14.41B	141.73	−0.19%

Companies that serve the same markets: healthcare, life sciences.

Company	Mkt cap	Price	Today
Ascendis Pharma A/SASND · life sciences · healthcare	15.70B	238.58	+1.81%
CSL LimitedCSL.AX · life sciences · healthcare	94.10B	196.08	−0.11%
BeOne Medicines AG6160.HK · life sciences · healthcare	342.24B	231.400	+2.66%
Clinuvel Pharmaceuticals LimitedCUVL · life sciences · healthcare	258.49M	5.12	−1.35%
Hansa Biopharma AB (publ)HNSA.ST · life sciences · healthcare	3.75B	37.60	−1.62%
Aurinia Pharmaceuticals Inc.AUPH · life sciences · healthcare	2.25B	16.94	+1.16%
Ultragenyx Pharmaceutical Inc.UP0.F · life sciences · healthcare	1.39B	14.14	+6.28%
Corcept Therapeutics IncorporatedCORT · life sciences · healthcare	12.67B	117.17	+0.62%

What visitors to Halozyme Therapeutics's page also look at.

Company	Mkt cap	Price	Today
NEUROCRINE BIOSCIENCES INC.NB3.F	12.78B	125.70	+4.32%
Ultragenyx Pharmaceutical Inc.RUP0.F	1.39B	14.14	+6.28%
Arrowhead Pharmaceuticals Inc.RHDP1.F	7.47B	52.90	+1.11%
UNITED THERAPEUTICS CORP.(DEL.RUTH.F	21.03B	490.20	−1.45%
Jazz Pharmaceuticals PLCJ7Z.F	12.28B	189.10	−0.24%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All RV7.F news ›

Defense World·3d agoNegative

Halozyme Therapeutics, Inc. $HALO Stock Position Cut by First Citizens Bank & Trust Co.

Posted by Defense World Staff on Oct 18th, 2026 Here are the key news stories impacting Halozyme Therapeutics this week: View Our Latest Report on HALO Halozyme licenses its technology to pharmaceutical and biotechnology companies, which…

CNBC·5d ago

Inside Edge’s Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance

CNBC Inside Edgeâs Todd Gordon: Halozyme Therapeutics are beating estimates; raised full-year guidance

Markets Daily·Oct 14Positive

Halozyme Therapeutics (NASDAQ:HALO) Stock Price Up 5.9% After Analyst Upgrade

Posted by Sarita Garza on Oct 14th, 2026 View Our Latest Stock Report on Halozyme Therapeutics The company has a quick ratio of 2.31, a current ratio of 2.71 and a debt-to-equity ratio of 13.50. The business has a 50-day moving average…

MarketScreener·Oct 7Positive

Halozyme Therapeutics Wins Injunction Barring Manufacture, Sale of Merck's Keytruda SC in Multiple EU Markets

... Merck & Co., Inc. Halozyme Therapeutics Wins Injunction Barring Manufacture, Sale of Merck's Keytruda SC in Multiple EU Markets Published on 10/07/2026 at 08:48 am EDT Latest news about Merck & Co., Inc. Chart Merck & Co., Inc. Income…

Stock Titan·Oct 2

[Form 3] HALOZYME THERAPEUTICS, INC. Initial Statement of Beneficial Ownership

Halozyme Therapeutics (HALO) is a San Diego-based biopharmaceutical company focused on ENHANZE and Hypercon drug delivery technologies for subcutaneous biologics. - [Form 3] HALOZYME THERAPEUTICS, INC. Initial Statement of Beneficial…

From articles in the 4Search news index.

In the news

7mentions in 30 days

7with it in the headline

Positivesentiment

Most coverage from

stocktitan.net2
cnbc.com1
defenseworld.net1
marketscreener.com1
themarketsdaily.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.